Healthcare: 3 Tough Luck Tumbles – Are They Buys?

Industry Focus - En podkast av The Motley Fool

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

Kategorier:

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY

Visit the podcast's native language site